| Prev Close | 11.34 |
| Day Low/High | 10.63 / 11.27 |
| 52 Wk Low/High | 8.60 / 25.39 |
Amicus Therapeutics, Inc. (FOLD)
10.80
NASDAQ
| Exchange | NASDAQ |
| Shares Outstanding | 278.64B |
| Market Cap | 3.16B |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
A Biotech Trio to Like Going Into 2017
Egalet, Portola Pharmaceuticals and Amicus Therapeutics hold promise for improvement.
4 Promising Small Biotechs to Watch in 2017
Veterinary drug play Aratana Therapeutics is among the potential solid performers next year.
TG Therapeutics Looks Like a Healthy Play
Small biotech tanked on weak earnings, but still seems promising.
3 Biotech-Investing Mistakes to Avoid
These are the biggest errors that I've made over the years.
5 Small-Cap Biotechs With Big Potential
These 5 stocks all have positive catalysts on the horizon.
5 Small-Cap Biotechs With Big Potential
These 5 stocks all have positive catalysts on the horizon.
2 Small Biotech Stocks With Big Milestones
As Brexit turmoil calms down, let's get back to small cap stocks.
Warren Buffett Is Satisfied With IBM, but Jim Cramer Wants More
Warren Buffett is satisfied with his IBM holdings, but is Jim Cramer satisfied with the stock? Not exactly.
Some Good News Amid Market Wreckage
Momentum is elusive, but speculation is still healthy.
Market Remains Deceptive
Momentum is lacking for new highs.
There's Action Below the Surface
Biotechs are still bubbly in 'stock pickers' market.
Cramer: Bob Dylan Was Right
The answer is blowing in the currency headwind.
The Trader Daily
Be wary of any early session strength.
The Trader Daily
Day-timeframe traders should be concerned with supply.
Oil Lang Syne
The market's oil worries are long forgotton.
A Nice Taste of Holiday Trading
Not a big day for the indices, but the underlying action improved.
A Joke That Is Not Funny
"Everything must be fine."
